Received Jun 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Z004301 | IM / LA |
Patient presented to office for visit on 6/3/25 for "allergic reaction to injection" following Capvaxive administration on 5/30/25. Vaccine was administered in Left deltoid and patient reported redness at the site which was endorsed by the provider but denied pain at the site. No warmth at the site noted by the provider. Provider stated injection site was not concerning for cellulitis. Pt reported subjective fever and chills the evening after receiving vaccination, though she never took her temperature at home to confirm fever and was afebrile during her appointment. She also presented with fever blisters around her mouth. No other symptoms of concern reported by patient. Provider treated Herpes labialis with Valacyclovir 2000 mg BID for one day. Provider recommended warm moist compress to the area, Tylenol and Ibuprofen PRN, and reviewed red flag warning signs and emergency precautions for injection site reaction per note.
None reported.
GERD without esophagitis; Diabetes mellitus; Sleep apnea; Mild intermittent asthma with acute exacerbation; Cervical myofascial pain syndrome; Obesity; Chronic cough; Chronic tension-type headache, intractable; Spinal stenosis; Mixed hyperlipiedmia
Fluticasone Propion-Salmeterol (Advair Diskus) 250-50 mcg/dose diskus; Aspirin 81 mg chewable tablet; Albuterol HFA 90 mcg/actuation inhaler
Meperidine; Dilantin; Hydrocodone; Morphine; Oxycodone
None.